The distribution of pathogenic variants in our BBS cohort was similar to other recent studies from Europe and the USA with a predominance of pathogenic variations in BBS1 and BBS10 [9–11], but differed from a study in China, where the majority of patients were affected by mutations in BBS2 and BBS7 [42]. This evidence concerns the gene BBS1 and Bardet-Biedl syndrome.